$GILD Recent Headlines 10 S&P 500 companies gr
Post# of 94182
Posted On: 08/20/2014 10:24:03 AM
$GILD Recent Headlines
10 S&P 500 companies growing faster than their rivals 3:29 a.m. Today - Philip van Doorn
10 stocks enjoying the biggest increases in earnings estimates 7:27 p.m. Aug. 12, 2014 - Philip van Doorn
Gilead offers to sell Hepatitis C drug in India at 99% off U.S. prices 4:17 p.m. Aug. 8, 2014 - blogs.marketwatch.com
Gilead says EU Committee to recommend approval of leukemia drug 7:32 a.m. July 25, 2014 - Ciara Linnane
Gilead says EU Committee to recommend approval of leukemia drug 7:26 a.m. July 25, 2014 - Ciara Linnane
S&P 500 ekes out another record close: stock market live blog recap 4:03 p.m. July 24, 2014 - blogs.marketwatch.com
Facebook surges to record; SodaStream bubbles higher 1:23 p.m. July 24, 2014 - Tom Bemis
Biotechs beat estimates, but the Street wants more 11:44 a.m. July 24, 2014 - blogs.marketwatch.com
Gilead trounces earnings views, but shares don't feel the after-hours love 5:39 p.m. July 23, 2014 - blogs.marketwatch.com
Updates, advisories and surprises 5:31 p.m. July 23, 2014 - MarketWatch
Facebook rallies in after hours as results top outlook 4:58 p.m. July 23, 2014 - Sue Chang
Biogen results crush consensus 4:55 p.m. July 23, 2014 - The Trading Deck
Gilead trounces estimates on strong Sovaldi sales 4:19 p.m. July 23, 2014 - MarketWatch.com
Gilead trounces estimates for earnings, sales, Sovaldi 4:17 p.m. July 23, 2014 - Russ Britt
Gilead Sovaldi sales reach $3.48B, ahead of $2.87B view 4:10 p.m. July 23, 2014 - Russ Britt
Gilead's $6.53B in revs. beats $5.85B estimate 4:10 p.m. July 23, 2014 - Russ Britt
Gilead adj. earns are $2.36/share vs. view of $1.79 4:09 p.m. July 23, 2014 - Russ Britt
Gilead revs. $6.5 billion vs. year-ago $2.77 billion 4:08 p.m. July 23, 2014 - Russ Britt
Gilead Q2 net is $2.20 vs. year-ago 46 cents 4:07 p.m. July 23, 2014 - Russ Britt
4 ways Gilead’s earnings will impact every American 1:30 p.m. July 23, 2014 - Tim Mullaney
The Medical Innovation Threat 7:06 p.m. Aug. 19, 2014 - The Wall Street Journal Interactive Edition
Will Roche (RHHBY) Buy the Remaining Stake in Chugai? - Analyst Blog 5:55 p.m. Aug. 19, 2014 - Zacks.com
Amgen (AMGN) Reports Encouraging Top-Line Data on AMG 416 - Analyst Blog 5:25 p.m. Aug. 19, 2014 - Zacks.com
Pfizer Submits Palbociclib Marketing Application to the FDA - Analyst Blog 4:20 p.m. Aug. 19, 2014 - Zacks.com
Biogen Strengthens MS Portfolio with Plegridy FDA Approval - Analyst Blog 1:20 p.m. Aug. 19, 2014 - Zacks.com
Gilead Beats Apple To $100. Who Will Win Race To $120? 1:09 p.m. Aug. 19, 2014 - Seeking Alpha
PDL BioPharma Misses on Q2 Earnings due to Higher Expenses - Analyst Blog 9:10 a.m. Aug. 19, 2014 - Zacks.com
Celladon Corp. (CLDN) Jumps: Stock Adds 11.3% in Session - Tale of the Tape 8:51 a.m. Aug. 19, 2014 - Zacks.com
A Market-Beating Veteran on 11 Undervalued Stocks 7:46 a.m. Aug. 19, 2014 - Barrons.com
Gilead’s Chart Scores Another Victory Following a Legal One 8:03 p.m. Aug. 18, 2014 - InvestorPlace.com
New Magic Formula Stocks From Joel Greenblatt: CBI, DAL, GILD, MNST, ROST, LUV 5:44 p.m. Aug. 18, 2014 - GuruFocus.com
Achillion Pharmaceuticals Soars on Mid-Stage HCV Study Data - Analyst Blog 4:45 p.m. Aug. 18, 2014 - Zacks.com
Should Achillion Pharma (ACHN) Be In Your Portfolio Now? - Stocks in the News 3:20 p.m. Aug. 18, 2014 - Zacks.com
Roche's Avastin Approved by FDA for Advanced Cervical Cancer - Analyst Blog 2:30 p.m. Aug. 18, 2014 - Zacks.com
Gilead Scores Legal Victory Over Roche for Sovaldi, Shares Up - Analyst Blog 1:34 p.m. Aug. 18, 2014 - Zacks.com
Achillion Pharmaceuticals Up On Buyout Rumors 12:52 p.m. Aug. 18, 2014 - Investors Business Daily
Jazz, Celgene Lead Top 4 Drugmaker Profit Margins 12:46 p.m. Aug. 18, 2014 - Investors Business Daily
Jim Cramer Answers Twitter (TWTR) Questions on Walmart (WMT), Yelp (YELP), Kinder Morgan (KMI) and More 12:40 p.m. Aug. 18, 2014 - TheStreet.com
#PreMarket Primer: Monday, August 18: Jackson Hole Draws Market Attention 6:12 a.m. Aug. 18, 2014 - benzinga.com
'Fast Money' Recap: Getting Defensive in a Volatile World 5:00 a.m. Aug. 16, 2014 - TheStreet.com
Technical Updates, Drug Recommendations, and Upcoming Events - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Humana 9:20 a.m. Aug. 19, 2014 - PR Newswire - PRF
Positive Opinion on the Drug, Acquisition, Orphan Drug Designation, Analysis Results, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Tenet Health 9:10 a.m. Aug. 8, 2014 - PR Newswire - PRF
Critical Alerts For Groupon, Gilead Sciences, Ballard Power Systems, GlaxoSmithKline, and Eli Lilly Released By InvestorsObserver 9:31 a.m. Aug. 4, 2014 - PR Newswire - PRF
Complete Response Letter from FDA, Positive Opinion on Drug, Technical Update, Financial Result Release, and Clinical Trial Results - Research Reports on AcelRx, Horizon, Gilead, AbbVie and Exelixis 9:20 a.m. July 31, 2014 - PR Newswire - PRF
Market Momentum on Biotech Stocks -- IsoRay, Neurocrine Biosciences, OPKO Health, Orexigen Therapeutics, and Gilead Sciences 8:40 a.m. July 31, 2014 - PR Newswire - PRF
Theraclone Announces Exclusive Agreement with Gilead Sciences for Broadly Neutralizing HIV Antibodies 8:00 a.m. July 30, 2014 - BusinessWire - BZX
European CHMP Adopts Positive Opinion for Gilead’s Zydelig® (idelalisib) for the Treatment of Chronic Lymphocytic Leukemia and Follicular Lymphoma 7:24 a.m. July 25, 2014 - BusinessWire - BZX
Galectin, Intercept, Others Vying for Lead Drugs in NASH Epidemic 10:03 a.m. July 24, 2014 - ACCESSWIRE
The Medicines Patent Pool (MPP) Broadens Collaboration with Gilead Sciences: Signs Licence for Phase III Medicine Tenofovir Alafenamide (TAF) 12:30 a.m. July 24, 2014 - PR Newswire - PRF
Gilead Announces New Agreement with Medicines Patent Pool for Access to Medicines in Developing World Countries 12:00 a.m. July 24, 2014 - BusinessWire - BZX
U.S. Food and Drug Administration Approves Gilead’s Zydelig® (idelalisib) for Relapsed Chronic Lymphocytic Leukemia, Follicular Lymphoma and Small Lymphocytic Lymphoma 11:49 a.m. July 23, 2014 - BusinessWire - BZX
Gilead Sciences to Release Second Quarter 2014 Financial Results on Wednesday, July 23, 2014 5:00 p.m. July 16, 2014 - BusinessWire - BZX
Critical Alerts For SunEdison, Twitter, Gilead Sciences, Darden Restaurants, and Blackrock Released By InvestorsObserver 9:31 a.m. July 14, 2014 - PR Newswire - PRF
NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind 5:20 a.m. July 4, 2014 - PR Newswire - PRF
Dividends, Mergers, and Study Results - Analyst Notes on Pfizer, Gilead, Pacira, QLT and Agenus 6:30 a.m. July 1, 2014 - PR Newswire - PRF
AIDSVu Releases New Maps that Depict Impact of HIV in American Cities 9:50 a.m. June 27, 2014 - BusinessWire - BZX
Top White House AIDS Official Visits San Francisco Clinic on National HIV Testing Day 9:00 a.m. June 27, 2014 - PR Newswire - PRF
Gilead Submits New Drug Application to Japan’s Pharmaceutical and Medical Devices Agency for Sofosbuvir for Chronic Hepatitis C 3:01 a.m. June 27, 2014 - BusinessWire - BZX
Biotechnology Equities Technical Notes -- Research on StemCells, Gilead Sciences, Galena Biopharma, and Inovio Pharma 7:10 a.m. June 26, 2014 - PR Newswire - PRF
Gilead Sciences to Present at the Wells Fargo Healthcare Conference on Tuesday, June 17 5:00 p.m. June 16, 2014 - BusinessWire - BZX
10 S&P 500 companies growing faster than their rivals 3:29 a.m. Today - Philip van Doorn
10 stocks enjoying the biggest increases in earnings estimates 7:27 p.m. Aug. 12, 2014 - Philip van Doorn
Gilead offers to sell Hepatitis C drug in India at 99% off U.S. prices 4:17 p.m. Aug. 8, 2014 - blogs.marketwatch.com
Gilead says EU Committee to recommend approval of leukemia drug 7:32 a.m. July 25, 2014 - Ciara Linnane
Gilead says EU Committee to recommend approval of leukemia drug 7:26 a.m. July 25, 2014 - Ciara Linnane
S&P 500 ekes out another record close: stock market live blog recap 4:03 p.m. July 24, 2014 - blogs.marketwatch.com
Facebook surges to record; SodaStream bubbles higher 1:23 p.m. July 24, 2014 - Tom Bemis
Biotechs beat estimates, but the Street wants more 11:44 a.m. July 24, 2014 - blogs.marketwatch.com
Gilead trounces earnings views, but shares don't feel the after-hours love 5:39 p.m. July 23, 2014 - blogs.marketwatch.com
Updates, advisories and surprises 5:31 p.m. July 23, 2014 - MarketWatch
Facebook rallies in after hours as results top outlook 4:58 p.m. July 23, 2014 - Sue Chang
Biogen results crush consensus 4:55 p.m. July 23, 2014 - The Trading Deck
Gilead trounces estimates on strong Sovaldi sales 4:19 p.m. July 23, 2014 - MarketWatch.com
Gilead trounces estimates for earnings, sales, Sovaldi 4:17 p.m. July 23, 2014 - Russ Britt
Gilead Sovaldi sales reach $3.48B, ahead of $2.87B view 4:10 p.m. July 23, 2014 - Russ Britt
Gilead's $6.53B in revs. beats $5.85B estimate 4:10 p.m. July 23, 2014 - Russ Britt
Gilead adj. earns are $2.36/share vs. view of $1.79 4:09 p.m. July 23, 2014 - Russ Britt
Gilead revs. $6.5 billion vs. year-ago $2.77 billion 4:08 p.m. July 23, 2014 - Russ Britt
Gilead Q2 net is $2.20 vs. year-ago 46 cents 4:07 p.m. July 23, 2014 - Russ Britt
4 ways Gilead’s earnings will impact every American 1:30 p.m. July 23, 2014 - Tim Mullaney
The Medical Innovation Threat 7:06 p.m. Aug. 19, 2014 - The Wall Street Journal Interactive Edition
Will Roche (RHHBY) Buy the Remaining Stake in Chugai? - Analyst Blog 5:55 p.m. Aug. 19, 2014 - Zacks.com
Amgen (AMGN) Reports Encouraging Top-Line Data on AMG 416 - Analyst Blog 5:25 p.m. Aug. 19, 2014 - Zacks.com
Pfizer Submits Palbociclib Marketing Application to the FDA - Analyst Blog 4:20 p.m. Aug. 19, 2014 - Zacks.com
Biogen Strengthens MS Portfolio with Plegridy FDA Approval - Analyst Blog 1:20 p.m. Aug. 19, 2014 - Zacks.com
Gilead Beats Apple To $100. Who Will Win Race To $120? 1:09 p.m. Aug. 19, 2014 - Seeking Alpha
PDL BioPharma Misses on Q2 Earnings due to Higher Expenses - Analyst Blog 9:10 a.m. Aug. 19, 2014 - Zacks.com
Celladon Corp. (CLDN) Jumps: Stock Adds 11.3% in Session - Tale of the Tape 8:51 a.m. Aug. 19, 2014 - Zacks.com
A Market-Beating Veteran on 11 Undervalued Stocks 7:46 a.m. Aug. 19, 2014 - Barrons.com
Gilead’s Chart Scores Another Victory Following a Legal One 8:03 p.m. Aug. 18, 2014 - InvestorPlace.com
New Magic Formula Stocks From Joel Greenblatt: CBI, DAL, GILD, MNST, ROST, LUV 5:44 p.m. Aug. 18, 2014 - GuruFocus.com
Achillion Pharmaceuticals Soars on Mid-Stage HCV Study Data - Analyst Blog 4:45 p.m. Aug. 18, 2014 - Zacks.com
Should Achillion Pharma (ACHN) Be In Your Portfolio Now? - Stocks in the News 3:20 p.m. Aug. 18, 2014 - Zacks.com
Roche's Avastin Approved by FDA for Advanced Cervical Cancer - Analyst Blog 2:30 p.m. Aug. 18, 2014 - Zacks.com
Gilead Scores Legal Victory Over Roche for Sovaldi, Shares Up - Analyst Blog 1:34 p.m. Aug. 18, 2014 - Zacks.com
Achillion Pharmaceuticals Up On Buyout Rumors 12:52 p.m. Aug. 18, 2014 - Investors Business Daily
Jazz, Celgene Lead Top 4 Drugmaker Profit Margins 12:46 p.m. Aug. 18, 2014 - Investors Business Daily
Jim Cramer Answers Twitter (TWTR) Questions on Walmart (WMT), Yelp (YELP), Kinder Morgan (KMI) and More 12:40 p.m. Aug. 18, 2014 - TheStreet.com
#PreMarket Primer: Monday, August 18: Jackson Hole Draws Market Attention 6:12 a.m. Aug. 18, 2014 - benzinga.com
'Fast Money' Recap: Getting Defensive in a Volatile World 5:00 a.m. Aug. 16, 2014 - TheStreet.com
Technical Updates, Drug Recommendations, and Upcoming Events - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Humana 9:20 a.m. Aug. 19, 2014 - PR Newswire - PRF
Positive Opinion on the Drug, Acquisition, Orphan Drug Designation, Analysis Results, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Tenet Health 9:10 a.m. Aug. 8, 2014 - PR Newswire - PRF
Critical Alerts For Groupon, Gilead Sciences, Ballard Power Systems, GlaxoSmithKline, and Eli Lilly Released By InvestorsObserver 9:31 a.m. Aug. 4, 2014 - PR Newswire - PRF
Complete Response Letter from FDA, Positive Opinion on Drug, Technical Update, Financial Result Release, and Clinical Trial Results - Research Reports on AcelRx, Horizon, Gilead, AbbVie and Exelixis 9:20 a.m. July 31, 2014 - PR Newswire - PRF
Market Momentum on Biotech Stocks -- IsoRay, Neurocrine Biosciences, OPKO Health, Orexigen Therapeutics, and Gilead Sciences 8:40 a.m. July 31, 2014 - PR Newswire - PRF
Theraclone Announces Exclusive Agreement with Gilead Sciences for Broadly Neutralizing HIV Antibodies 8:00 a.m. July 30, 2014 - BusinessWire - BZX
European CHMP Adopts Positive Opinion for Gilead’s Zydelig® (idelalisib) for the Treatment of Chronic Lymphocytic Leukemia and Follicular Lymphoma 7:24 a.m. July 25, 2014 - BusinessWire - BZX
Galectin, Intercept, Others Vying for Lead Drugs in NASH Epidemic 10:03 a.m. July 24, 2014 - ACCESSWIRE
The Medicines Patent Pool (MPP) Broadens Collaboration with Gilead Sciences: Signs Licence for Phase III Medicine Tenofovir Alafenamide (TAF) 12:30 a.m. July 24, 2014 - PR Newswire - PRF
Gilead Announces New Agreement with Medicines Patent Pool for Access to Medicines in Developing World Countries 12:00 a.m. July 24, 2014 - BusinessWire - BZX
U.S. Food and Drug Administration Approves Gilead’s Zydelig® (idelalisib) for Relapsed Chronic Lymphocytic Leukemia, Follicular Lymphoma and Small Lymphocytic Lymphoma 11:49 a.m. July 23, 2014 - BusinessWire - BZX
Gilead Sciences to Release Second Quarter 2014 Financial Results on Wednesday, July 23, 2014 5:00 p.m. July 16, 2014 - BusinessWire - BZX
Critical Alerts For SunEdison, Twitter, Gilead Sciences, Darden Restaurants, and Blackrock Released By InvestorsObserver 9:31 a.m. July 14, 2014 - PR Newswire - PRF
NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind 5:20 a.m. July 4, 2014 - PR Newswire - PRF
Dividends, Mergers, and Study Results - Analyst Notes on Pfizer, Gilead, Pacira, QLT and Agenus 6:30 a.m. July 1, 2014 - PR Newswire - PRF
AIDSVu Releases New Maps that Depict Impact of HIV in American Cities 9:50 a.m. June 27, 2014 - BusinessWire - BZX
Top White House AIDS Official Visits San Francisco Clinic on National HIV Testing Day 9:00 a.m. June 27, 2014 - PR Newswire - PRF
Gilead Submits New Drug Application to Japan’s Pharmaceutical and Medical Devices Agency for Sofosbuvir for Chronic Hepatitis C 3:01 a.m. June 27, 2014 - BusinessWire - BZX
Biotechnology Equities Technical Notes -- Research on StemCells, Gilead Sciences, Galena Biopharma, and Inovio Pharma 7:10 a.m. June 26, 2014 - PR Newswire - PRF
Gilead Sciences to Present at the Wells Fargo Healthcare Conference on Tuesday, June 17 5:00 p.m. June 16, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼